Halothane-verapamil causes regional myocardial dysfunction in the dog

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• Verapamil is a calcium channel blocker used to treat cardiovascular conditions.
• Anesthetic agents like halothane can influence cardiac function.
• Understanding drug interactions and their effects on regional myocardial function is crucial.

Purpose of the Study:

• To investigate the effects of increasing intravenous doses of verapamil on regional myocardial function in dogs under halothane anesthesia.
• To determine if verapamil induces regional dysfunction similar to nifedipine.

Main Methods:

• Sonomicrometry was used to measure regional myocardial function in six mongrel dogs.
• Dogs were anesthetized with halothane (1% inspired).
• Increasing intravenous doses of verapamil were administered.

Main Results:

• Verapamil administration led to increased end-diastolic length and reduced systolic shortening.
• An abnormal, paradoxical contraction pattern was observed in the apical region.
• These effects occurred without coronary artery damage or signs of ischemia.

Conclusions:

• Verapamil, in the presence of halothane anesthesia, induces regional myocardial dysfunction.
• The observed dysfunction is similar to that caused by intracoronary nifedipine.
• This suggests a potential for drug-induced regional cardiac impairment.